Should You Continue to Hold OMCL Stock in Your Portfolio?
Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
Open original sourceLoading market dashboard
Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
Open original source